Abstract
Esophageal varices, because of their tendency to cause massive gastrointestinal hemorrhage, represent the more significant part of the portosystemic collateral circulation that develops in response to a chronic increase in portal pressure [1]. In recent years, much interest has been paid to the development of objective techniques allowing the quantification of hemodynamic abnormalities at the varices [2–4]. This has been mainly due to the recognition that, contrary to measurements of portal pressure, the endoscopic assessment of the size and appearance of the varices bear a good correlation with the likelihood of variceal hemorrhage [5–7]. This suggests that direct hemodynamic measurements at the varices may shed more light on the pathophysiology of bleeding and allow a better evaluation of new therapeutic approaches for portal hypertension [1,2,8,9].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bosch J, Navasa M, García-Pagán JC, DeLacy AM, Rodés J (1989) Portal Hypertension. Med Clin North Am 73: 931–953
Bosch J, Bordas JM, Rigau J, Viola C, Mastai R, Kravetz D, Navasa M, Rodés J (1986) Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: Comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy. Hepatology 6: 667–672
Bosch J, Groszmann RJ (1984) Measurement of azygos venous blood flow by a continuous thermal dilution technique: An index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology 4: 424–429
Mosimann R (1982) Non-aggressive assessment of portal hypertension using endoscopie measurement of variceal pressure. Preliminary report. Am J Surg 143: 212–214
Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M (1981) Prediction of variceal hemorrhage on esophageal endoscopy. Gastrointest Endosc 27: 213–218
Lebrec D, DeFleury P, Rueff B, Nahum H, Benhamou JP (1980) Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 79: 1139–1144
The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 319: 983–989
Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodés J (1985) Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients. J Hepatol 1: 125–139
Bosch J, Mastai R, Kravetz D, Navasa M, Rodés J (1986) Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis 6: 309–317
Polio J, Groszmann RJ (1986) Hemodynamic factors involved in the development and rupture of esophageal varices: A pathophysiologic approach to treatment. Semin Liver Dis 6: 318–331
Britton RC (1963) Influence of portal-systemic collateral patterns and distribution of varices on results of surgical treatment of bleeding esophageal varices. Surgery 53: 567–578
Butler H (1951) The veins of the esophagus. Thorax 6: 267–296
Hadengue A, Lee SS, Moreau R, Lebrec D (1987) Oxygen and bile acid content in the azygos blood. Clues to the azygos derivation in patients with portal hypertension. J Hepatol 5: 98–101
Calés P, Braillon A, Jirón MI, Lebrec D (1985) Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol. J Hepatol 1: 37–46
Biber B, Holm C, Winso O (1983) Portal blood flow in man during surgery, measured by a modification of the continuous thermodilution method. Scand J Gastroenterol 18: 233–239
Fronek A, Ganz W (1960) Measurement of flow in single blood vessels including cardiac output by local thermodilution. Circ Res 8: 175–182
Ganz W, Swan HJC (1974) Measurement of blood flow by the thermodilution technique. In: Bloomfield DA (ed) Dye curves: The theory and practice of indicator dilution. University Park Press, Baltimore, pp 245–266
Linzell JL (1966) Measurement of venous flow by continuous thermodilution and its application to measurement of mammary blood flow in the goat. Circ Res 18: 745–754
Friedman PL, Brown EJ, Gunther S, Alexander RW, Barry WH, Mudge GH, Grossman W (1981) Coronary vasoconstrictor effect of indomethacin in patients with coronary artery disease. N Engl J Med 305: 1171–1175
Ganz W, Tamura K, Marcus HS (1971) Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 44: 181–195
García-Tsao G, Groszmann RJ (1987) Portal hemodynamics during nitroglycerin administration in cirrhotic patients. Hepatology 7: 805–809
Haggmark S, Biber B, Sjodoin J (1982) The continuous thermodilution method for measuring high blood flows. Scand J Clin Lab Invest 42: 315–321
Mastai R, Grande L, Bosch J, Bruix J, Rigau J, Kravetz D, Navasa M, Pera C, Rodés J (1986) Effects of metoclopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension. Hepatology 6: 1244–1247
Viola C, Bosch J, Mastai R, Terés J, Navasa M, Kravetz D, Grima N, Rodés J (1987) Prognostic value of measurements of portal pressure in patients with cirrhosis. J Hepatol 5 (Suppl. 1): S 71
Mastai R, Bosch J, Bordas JM, Bruix J, Kravetz D, Viola C, Rodés J (1985) Efecto de la esclerosis de varices esofágicas sobre el flujo sanguíneo de la vena ázigos en pacientes con hipertensión portal. Gastroenterol Hepatol 8: 174
Bosch J (1985) Effect of pharmacological agents on portal hypertension: A haemodynamic appraisal. Clin Gastroenterol 14: 169–184
Bosch J, Mastai R, Kravetz D, Bruix J, Gaya J, Rigau J, Rodés J (1984) Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 4: 1200–1205
García-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J (1990) Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. Hepatology 11: 230–238
Hadengue A, Lee SS, Moreau R, Braillon A, Lebrec D (1987) Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: Possible role of serotoninergic mechanisms in portal hypertension. Hepatology 7: 644–647
Mastai R, Bosch J, Navasa M, Kravetz D, Bruix J, Viola C, Rodés J (1987) Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis. J Hepatol 4: 71–79
Moreau R, Lee SS, Hadengue A, Braillon A, Lebrec D (1987) Hemodynamic effects of a clonidine-induced decrease in sympathetic tone in patients with cirrhosis. Hepatology 7: 149–154
Navasa M, Chesta J, Bosch J, Rodés J (1989) Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function. Gastroenterology 96: 1110–1118
Ruiz del Arbol L, García-Pagán JC, Feu F, Pizcueta P, Navasa M, Bosch J, Rodés J (1989) Effects of molsidomine, a long-acting venous dilator, on hepatic haemodynamics in patients with cirrhosis and portal hypertension. J Hepatol 9: S 86
Groszmann RJ, Kravetz D, Bosch J, Glickman M, Bruix J, Bredfeldt J, Conn HO, Rodés J (1982) Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology 2: 757–762
Bosch J, Kravetz D, Rodés J (1981) Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin. Gastroenterology 80: 518–525
Bosch J, Kravetz D, Mastai R, Bruix J, Rigau J, Rodés J (1983) Azygos venous blood flow in cirrhosis: Effects of balloon tamponade, vasopressin, somatostatin and propranolol. Hepatology 3: 855
Bosch J, Bordas JM, Mastai R, Kravetz D, Navasa M, Chesta J, Pizcueta P, García-Pagán JC, Rodés J (1988) Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: Comparison with the effects on portal pressure. Hepatology 8: 861–865
Kroeger RJ, Groszmann RJ (1985) Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model. Hepatology 5: 97–101
Pizcueta P, De Lacy AM, Kravetz D, Bosch J, Rodés J (1989) Propranolol decreases portal pressure without changing porto collateral resistance in cirrhotic rats. Hepatology 10 953–957
Navasa M, García-Pagán JC, Chesta J, Bru C, Pizcueta P, Casamitjana R, Bosch J, Rodés J (1989) Cambios posprandiales de la presión portal en la cirrosis hepática. Relatión con los niveles de glucagón plasmático. Gastroenterol Hepatol 12: 231–232
Lee SS, Moreau R, Hadengue A, Cerini R, Koshy A, Lebrec D (1988) Glucagon selectively increases splanchnic blood flow in patients with well-compensated cirrhosis. Hepatology 8: 1501–1505
Silva G, Navasa M, Bosch J, Chesta J, Pizcueta P, Casamitjana R, Rivera F, Rodés J (1990) Hemodynamic effects of glucagön in portal hypertension. Hepatology 11: 668–673
Valla D, Gaudin C, Geoffroy P, Braillon A, Lee SS, Lebrec D (1987) Reversal of adrenaline-induced increase in azygos blood flow in patients with cirrhosis receiving propranolol. J Hepatol 4: 86–92
Feu F, García-Pagán JC, Ruiz del Arbol L, De Lacy AM, Navasa M, Bosch J, Rodés J (1989) Favorable effects of propranolol in patients with malfunctioning porto-caval or distal splenorenal shunts. J Hepatol 9 (Suppl 1): S 149
Burns P, Taylor K, Blei AT (1987) Doppler flowmetry and portal hypertension. Gastroenterology 92: 824–826
Navasa M, Bosch J, Chesta J, Bru C, Pizcueta P, García-Pagán JC, Betz C, Casamitjana R, Rodés J (1988) Hemodynamic effects of subcutaneous administration of SMS 201-995, a long acting somatostatin analog, in patients with cirrhosis and portal hypertension. J Hepatol 7 (Suppl 1): S 64
Koshy A, Hadengue A, Lee SS, Jiron MI, Lebrec D (1987) Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis. Clin Pharmacol Ther 42: 295–298
Hadengue A, Moreau R, Cerini R, Koshy A, Lee SS, Lebrec D (1989) Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: Search for an additive effect. Hepatology 9: 83–87
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Japan
About this chapter
Cite this chapter
Bosch, J., Feu, F., García-Pagán, JC. (1991). Measurement of Azygos Blood Flow. In: Okuda, K., Benhamou, JP. (eds) Portal Hypertension. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68361-2_11
Download citation
DOI: https://doi.org/10.1007/978-4-431-68361-2_11
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68363-6
Online ISBN: 978-4-431-68361-2
eBook Packages: Springer Book Archive